JAKARTA - PT Sido Muncul Herbal and Pharmaceutical Industry Tbk wants to share blessings with its shareholders. The issuer with the stock code SIDO will distribute an interim dividend for the 2021 financial year.
This is the decision of the Board of Directors of the Company on August 4, 2021, and the approval of the Board of Commissioners based on the decision in the meeting of the Board of Commissioners held on July 16, 2021.
In the SIDO information disclosure, on the Indonesia Stock Exchange (IDX) website, quoted on Monday 9 August, the company owned by conglomerate Irwan Hidayat will distribute an interim cash dividend of Rp 15.30 per share for the 2021 financial year period January 1, 2021, to June 30, 2021.
Cash dividends will be distributed to shareholders whose names are recorded in the Register of Shareholders of the Company (Recording Date) on August 18, 2021, until 16.00 western Indonesia time, and/or Shareholders of the Company in Sub Securities Accounts at the Indonesian Central Securities Depository (KSEI) at the close of trading, August 18, 2021.
The dividend will be distributed to shareholders on August 27, 2021.
SEE ALSO:
For information, Sido Muncul recorded an increase in net profit in the second semester of 2021. In its financial statements as of June 30, 2021, the producer of Tolak Angin recorded a net profit of Rp502 billion or 21.31 percent higher than June 30, 2020, which was Rp413.79 billion.
Meanwhile, Sido Muncul's sales were recorded at Rp1.65 trillion in the first semester of 2021, an increase of 13.36 percent compared to the same period in the previous year of Rp1.45 trillion with basic earnings per share of Rp16.86.
"In the midst of the pandemic, the company's product sales continue to grow amid the COVID-19 pandemic. The products that are the favorites of customers are Tolak Angin, ginger drink products, Vitamin C, Vitamin D, JSH, and Sambiloto which increases endurance," said the Director. Sido appears Leonard.
This growth was based on an increase in sales of 13% to Rp 1.65 trillion until the first semester of 2021, compared to the same period the previous year of Rp 1.50 trillion. Several products that recorded a surge in sales volume were Tolak Angin products and other supplements and vitamin products.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
